MedTrace Logo

Intensified Acute Kidney Disease Care to Reduce Chronic Kidney Disease

NCT04145609 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 690

Last updated 2019-10-30

No results posted yet for this study

Summary

Strategies to stop AKI-AKD-CKD continuum - Policy is one of the collaborative projects, Strategies to stop AKI-AKD-CKD continuum, Epidemiology, Immunology, Repair, Artificial intelligence, and Policy (EIRAP). It is aimed to study effective interventional strategies that lower the incidence of CKD among patients with AKD. The intensified AKD care to reduce CKD (ISACC trial) is a prospective, open-labeled, randomized controlled trial is designed to evaluate the efficacy of multidisciplinary team care (MDT) model and acute kidney disease (AKD) clinic visits

Conditions

  • Acute Kidney Injury
  • Renal Insufficiency, Chronic
  • Acute Kidney Disease
  • Decision Support Systems, Clinical

Interventions

BEHAVIORAL

Multidisciplinary team (MDT) care and Acute kidney disease (AKD) clinic

Multidisciplinary team (MDT) care: NPDS care model Acute kidney disease (AKD) clinic: layered approach

Sponsors & Collaborators

  • National Health Research Institutes, Taiwan

    collaborator OTHER

  • Taipei Medical University

    collaborator OTHER

  • Taipei Medical University Shuang Ho Hospital

    lead OTHER

Principal Investigators

  • Mai-Szu Wu · Shuang Ho Hospital, Taipei Medical University

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-01
Primary Completion
2020-12-31
Completion
2021-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04145609 on ClinicalTrials.gov